(Q44720795)

5 December 2017

Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats (English)

1 reference

5 December 2017

1 reference

Hui Liu

1

1 reference

5 December 2017

Ren Tang

2

1 reference

5 December 2017

Wei-San Pan

3

1 reference

5 December 2017

Yi Zhang

4

1 reference

5 December 2017

Hong Liu

5

1 reference

5 December 2017

language of work or name

1 reference

1 November 2003

1 reference

Journal of Pharmacy and Pharmacology

5 December 2017

1 reference

5 December 2017

55

1 reference

5 December 2017

11

1 reference

5 December 2017

1523-1529

1 reference

Converting a peptide into a drug: strategies to improve stability and bioavailability

5 December 2017

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Biomembrane permeability of peptides: strategies to improve their mucosal uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Phenylpropionic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Protein drug oral delivery: the recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Human jejunal effective permeability and its correlation with preclinical drug absorption models

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Design of nanoparticles composed of graft copolymers for oral peptide delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide delivery from nonoral routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Optimizing oral absorption of peptides using prodrug strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Innovative strategies for the oral delivery of drugs and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Effects of sodium glycocholate and protease inhibitors on permeability of TRH and insulin across rabbit trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Electrophysiological studies on the mechanism for enhanced intestinal transport of water-soluble compounds by antibiotic peptide bacitracin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Use of protease inhibitors to improve calcitonin absorption from the small and large intestine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

[Improvement of transmucosal absorption of biologically active peptide drugs]

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022052

21 January 2018

Identifiers

DOI

10.1211/0022357022052

1 reference

5 December 2017

1 reference